Related Experiment Videos
Continuous infusion of vancomycin in methicillin-resistant staphylococcus infection
A Di Filippo1, A R De Gaudio, A Novelli
1Institute of Anesthesiology and Intensive Care, University of Florence, Italy.
Chemotherapy
|January 28, 1998
Summary
Continuous infusion vancomycin improved organ function and white blood cell response in critically ill patients with methicillin-resistant Staphylococcus aureus (MRSA) infections. However, this method did not alter the overall disease progression compared to intermittent dosing.
Area of Science:
- Infectious Diseases
- Critical Care Medicine
- Pharmacology
Background:
- Methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-resistant coagulase-negative staphylococci (MRCNS) are significant causes of hospital-acquired infections.
- Vancomycin is a key antibiotic for treating MRSA/MRCNS infections, but optimal administration strategies remain under investigation.
Purpose of the Study:
- To compare the therapeutic efficacy of vancomycin administered via intermittent infusion versus continuous infusion in critically ill patients with MRSA/MRCNS infections.
- To evaluate the impact of different vancomycin administration methods on organ function and inflammatory markers.
Main Methods:
- A retrospective study was conducted in two intensive care units involving 25 critically ill patients with MRSA/MRCNS infections.
- Patients received vancomycin either as intermittent infusion (0.5 g every 6 hours) or continuous infusion (2 g/day).
- Sepsis-related Organ Failure Assessment (SOFA) scores and white blood cell (WBC) counts were assessed before and after treatment.
Main Results:
- Continuous vancomycin infusion (Group B) showed significant improvements in SOFA scores and a significant decrease in WBC counts post-treatment (p < 0.05).
- Intermittent vancomycin infusion (Group A) did not result in significant changes in SOFA scores or WBC counts.
- No significant differences were observed between the groups in SAPS II scores or length of hospital stay.
Conclusions:
- Continuous infusion of vancomycin appears to enhance organ function and modulate the leukocyte response in critically ill patients with MRSA/MRCNS infections.
- While continuous infusion improved specific clinical markers, it did not significantly alter the overall disease course or patient outcomes in this study.
- Further research may be warranted to fully elucidate the long-term benefits of continuous vancomycin infusion in severe infections.